DOC

Dr Martens

Stock
Stock
ISIN: GB00BL6NGV24
Ticker: DOCS
GB00BL6NGV24
DOCS

Price

Price

CHART BY

Historical dividends and forecast

Dr Martens has so far distributed $0.0339 in 2026. The next dividend will be paid on 09.04.2027


$0.0461

CHART BY

Frequently asked questions

The market capitalization of Dr Martens is 658.53M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Dr Martens is 27.85. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Dr Martens's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.0247. EPS indicates the company's profitability on a per-share basis.
Currently, 5 analysts cover Dr Martens's stock, with a consensus target price of 0.982. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Dr Martens reported a revenue of 764.90M.
Dr Martens's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is 145.70M. EBITDA measures the company's overall financial performance.
Dr Martens has a free cash flow of 116.30M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Dr Martens employs approximately 2,377 people. It operates in the Consumer Discretionary sector, specifically within the Apparel/ Footwear industry.
The free float of Dr Martens is 559.63M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
658.53M
EPS (TTM) 
$0.0247
Free Float 
559.63M
P/E ratio (TTM) 
27.85
Revenue (TTM) 
764.90M
EBITDA (TTM) 
145.70M
Free Cashflow (TTM) 
116.30M

Pricing

1D span
$0.913$0.939
52W span
$0.782$1.29

Analyst Ratings

The price target is 0.982 and the stock is covered by 5 analysts.

Buy

2

Hold

3

Sell

0

Information

Dr. Martens Plc engages in the manufacture and sale of footwear products. The firm offers boots, shoes, sandals, shoe care products, laces, and socks. It operates through the following geographical segments: EMEA, Americas, and APAC. The company was founded by Klaus Maertens in 1945 and is headquartered in London, the United Kingdom.

Employees
2,377
Industries
Apparel/ Footwear
Sector
Consumer Discretionary

Identifier

ISIN
GB00BL6NGV24
Primary Ticker
DOCS

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation